21
NPS Score
VS
Biogen Claimed Company
- EMPLOYEE
PARTICIPANTS - 193
- TOTAL
RATINGS
Esperion Therapeutics Claimed Company
- EMPLOYEE
PARTICIPANTS - 19
- TOTAL
RATINGS
Biogen vs Esperion Therapeutics
Compare Biogen versus Esperion Therapeutics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 193 employees and customers of Biogen and 19 employees and customers of Esperion Therapeutics.
Biogen
Biogen's brand is ranked #388 in the list of Global Top 1000 Brands, as rated by customers of Biogen. Their current market cap is $42.46B.
Esperion Therapeutics
Esperion Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Esperion Therapeutics. Their current market cap is $129.76M.
4/5
Product Quality
3.3/5
3.8/5
Pricing
2.7/5
3.8/5
Customer Service
3.1/5
| 53% | Promoters |
|---|---|
| 15% | Passive |
| 32% | Detractors |
Net Promoter Score
Winner by 21
0
NPS Score
| 45% | Promoters |
|---|---|
| 10% | Passive |
| 45% | Detractors |
See how Biogen compares to its competitors
See how Esperion Therapeutics compares to its competitors
Working at Biogen vs Working at Esperion Therapeutics
66 / 100
CEO Rating
Winner by 45%
21 / 100
CEO Rating
Biogen
Biogen doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Esperion Therapeutics
Employees at Esperion Therapeutics rate their CEO, Timothy Mayleben, 21/100. This score is 45% lower than the scores of Biogen's CEO, Michel Vounatsos.